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Community Acquired Rhinovirus Infection Is Associated With Changes 
 in the Airway Microbiome
To the Editor: 
Rhinoviruses (RV) infect up to 90% of school-age children with asthma during the month 6 
of September, and the severity of clinical illness varies from no symptoms to severe wheezing 7 
illnesses.(1) We previously reported that that detection by PCR of S. pneumoniae or M. 8 
catarrhalis in the upper airway is associated with RV-induced asthma exacerbations.(2) Based 9 
on those findings, we hypothesized that RV infection alters the upper airway microbiota, and that 10 
microbial changes correspond with infection severity. To test this hypothesis, we prospectively 11 
monitored respiratory symptoms in children with asthma during the peak fall RV season, 12 
obtained weekly nasal secretions, and concurrently analyzed these samples for RVs and airway 13 
bacteria.  14 
15 
 Children included in this analysis were enrolled in a larger study to determine genetic 16 
correlates with severe RV illnesses (“RhinoGen”). Subjects collected nasal mucus samples on a 17 
weekly basis for five consecutive weeks during September (peak RV season). All samples were 18 
analyzed for common respiratory viruses and RV abundance (qPCR), and RV typing was 19 
determined.(3) Cold and asthma symptoms recorded in daily diaries were linked with RV 20 
infection data to identify infections that were either asymptomatic or associated with an asthma 21 
exacerbation. RV-B types caused 70% of asymptomatic RV infections, while exacerbations were 22 
only associated with RV-A or RV-C types. This study included 10 RhinoGen participants with 23 
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asymptomatic infections and 7 participants with exacerbations of asthma (Table 1; Supplemental 24 
Figure 1; also see supplemental data for inclusion and exclusion criteria). Compared to the other 25 
children with asthma in the RhinoGen cohort, the children in the asymptomatic and the 26 
exacerbation groups had similar total IgE levels and rates of allergic sensitization (Supplemental 27 
Table 1). 16S rRNA gene sequencing was performed on bacterial DNA isolated from each 28 
sample and statistical analysis was performed to identify bacterial taxa associated with viral 29 
infection and RV-associated asthma exacerbations (see Online Repository). 30 
 31 
 Within the 34 samples before and after RV infection, the dominant phyla detected were 32 
Firmicutes (50.3%); Proteobacteria (24.9%); Actinobacteria (17%); Bacteroidetes (4.3%); 33 
Fusobacteria (1.5%); and unclassified (1.1%). The most abundant genera were Dolosigranulum 34 
(12.2% total abundance); Streptococcus (11.3%); Staphylococcus (10.1%); Corynebacterium 35 
(9.7%); Moraxella (7.2%); unclassified OTU #1 (5.6%); unclassified OTU #2 (3.1%); Neisseria 36 
(3%); Gemella (2.2%); Rothia (1.9%); Actinomyces (1.6%); Haemophilus (1.4%); Acinetobacter 37 
(1.4%) and unclassified OTU #3 (1.1%). We then compared the RV-negative and RV-positive 38 
samples, and found a similar number of overall sequences before and after RV infection 39 
(p=0.95); and similar evenness and diversity.  Furthermore, using principal component analysis 40 
(PCoA) of the Unifrac and Bray-Curtis distance matrices, there were no distinct clustering 41 
patterns between the two groups, suggesting that the overall community composition of the RV-42 
negative and RV-positive samples were similar.  43 
 44 
 In the combined asymptomatic and exacerbation groups, RV infection was associated 45 
with several significant changes in specific genera in airway secretions (Supplemental Figure 2). 46 
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RV infection was associated with increased abundance of Dolosigranulum (base mean=213; log2 47 
fold change=0.60) and Moraxella (base mean=116; log2 fold change=0.79), and reduced 48 
abundance of unclassified OTU #1 (base mean=209; log2 fold change=2.54). These findings 49 
support our previous report based on PCR detection that RV infection increases Moraxella 50 
detection,(2) and indicate that RV infection also influences microbial community composition.  51 
 52 
 We next tested whether microbial changes during RV infection differed between 53 
asymptomatic RV infections and RV-associated asthma exacerbations (Figure 1 and 54 
Supplemental Figure 3). RV infection was associated with increased abundance of Moraxella in 55 
both groups (asymptomatic group: base mean=175; log2 fold change=1.04; and exacerbation 56 
group: base mean=158; log2 fold change=0.9), and reduced abundance of unclassified OTU#1 57 
(asymptomatic group: base mean=269; log2 fold change=-3.6; and exacerbation group: base 58 
mean=123; log2 fold change=-1.12). Interestingly, RV associations with the abundance of some 59 
bacterial OTUs depended on the symptom group. Namely, within the asymptomatic group, RV 60 
infection was associated with increased abundance of Corynebacterium (base mean=196; log2 61 
fold change=0.48), while in the exacerbation group the association was in the opposite direction 62 
(base mean=212; log2 fold change=-0.45). RV infection was also associated with increased 63 
abundance of Dolosigranulum in the asymptomatic group (base mean=175; log2 fold 64 
change=1.04). 65 
  66 
 An association network constructed to link RV quantity with the presence of specific 67 
OTUs of bacteria demonstrated that as the quantity of RV increased, the abundance of 68 
Dolosigranulum and Corynebacterium decreased while the abundance of Haemophilus increased 69 
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(Supplemental figure 4). Furthermore, there were both increases and decreases of OTUs 70 
belonging to Streptococcus and Moraxella, indicating that the amount of RV replication is 71 
related to the magnitude of composition changes in the microbiome.(4)  72 
 73 
 Asymptomatic RV infections were associated with a significant increase in the 74 
abundance of Dolosigranulum and Corynebacterium compared to pre-infection samples, and the 75 
quantities of these bacteria were inversely correlated with viral shedding. Dolosigranulum and 76 
Corynebacterium are commensal bacteria within the respiratory tract in children and commonly 77 
co-occur.(5) They both are negatively associated with S. pneumoniae abundance, have been 78 
associated with reduced airway symptoms and a lower risk of otitis media during infancy,(6) and 79 
are inversely related to episodes of wheeze during infancy.(7) Our findings extend these findings 80 
and suggest that microbial communities featuring abundant Corynebacterium and possibly 81 
Dolosigranulum may confer protection against symptoms during RV infection. 82 
 83 
 This study has a number of advantages, and some limitations. The prospective study 84 
design allowed us to obtain samples from the same subject prior to and during RV infection. 85 
Samples were obtained during the same season, eliminating seasonal influences on microbial 86 
composition. Our findings are based on samples obtained from the upper airway for practical 87 
reasons. RV infections begin in the upper respiratory tract and thus the microbial environment in 88 
the upper airway is likely to influence initiation of RV infection and downstream events. 89 
Therefore investigations of the upper airway may identify new strategies for prevention and/or 90 
treatment of RV-induced exacerbations. Our results should be interpreted with caution due to the 91 
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small sample size, and the observational study design cannot distinguish causality among the 92 
observed associations between bacteria, viruses and symptoms. 93 
 In summary, RV infection is associated with changes in microbial composition of the 94 
upper airway. These changes differed between asymptomatic infection and exacerbation of 95 
asthma, and were related to RV quantity and possibly RV species.(8) While RV infection was 96 
generally related to increased abundance of Moraxella, a well-known airway pathogen; RV was 97 
related to increased commensal bacteria (Dolosigranulum and Corynebacterium) during 98 
asymptomatic infection. Finally, while bacterial pathogens such as Moraxella can contribute to 99 
respiratory symptoms, our findings suggest that other microbial communities may help to 100 
maintain normal airway physiology during RV infection and thereby moderate or prevent 101 
respiratory symptoms. Addressing these gaps in knowledge may lead to new preventive 102 
strategies for RV illnesses and virus-induced exacerbations of asthma. 103 
 104 
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 132 
Table I: Paired samples for analysis: 34 samples (17 pairs). Within each pair, the first sample 133 
was RV negative, and a second sample obtained 1-3 weeks later was RV positive.   134 
 135 
  136 
 
Asymptomatic during RV 
infection 
 
Moderate Asthma 
Exacerbation during RV 
infection 
 
RV-negative 
 
10 samples 
 
7 samples 
 
RV-positive 
 
10 samples 
 
7 samples 
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 137 
Figure 1: Relative abundance at the Genera level (OTUs >1%) between RV-negative and RV-138 
positive samples in the asymptomatic group (A) and asthma exacerbation group (B).  139 
Asymptomatic group: Dolosigranulum q-value=1.4x10-8; Corynebacterium q-value=1.5x10-111; 140 
Moraxella q-value=1.4x10-8; unclassified OTU#1 q-value=0. 141 
Exacerbation group: Corynebacterium q-value=7.8x10-25; Moraxella q-value=9.8x10-47; 142 
unclassified OTU#1 q-value=5.9x10-50. 143 
 144 
 145 
Capsule summary: In school-age children with asthma, RV infection changes the upper airway 146 
microbiome and these changes are associated with symptom severity and viral load. 147 
 148 
Key Words: Rhinovirus; microbiome; asthma; pediatric; bacteria. 149 
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Community Acquired Rhinovirus Infection Is Associated With Changes in the Airway 2 
Microbiome 3 
 4 
Online Data Supplement 5 
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Supplemental Methods 23 
 24 
Recruitment and Inclusion/Exclusion Criteria 25 
The study population was recruited from the general population in Madison, Wisconsin and 26 
surrounding areas via primary care physicians, allergy and asthma specialists and advertisements 27 
in the community.  The study was designed to be as inclusive as possible to reflect the general 28 
population. Any child with or without asthma, ages 4-12 years, was considered eligible for the 29 
study provided they did not have a history of prematurity, complications at birth, respiratory 30 
problems at birth or any other significant medical illness.  31 
 A subset of RhinoGen subjects were included in this pilot study based on the following 32 
criteria: 1) physician diagnosis of asthma per NHLBI and ATS criteria (1, 2); 2) the initial 33 
specimen tested negative for virus with an absence of cold and/or asthma symptoms for seven 34 
days prior to and four days following specimen collection; 3) the follow-up specimen tested 35 
positive for rhinovirus (and no other virus) and was the first viral infection since the initial 36 
specimen was collected; 4) the follow-up specimen was associated with either an absence of cold 37 
and asthma symptoms, or with an asthma exacerbation; and 4) enough sample remained for 38 
microbial analysis. Of the 310 eligible subjects, 29 met the above criteria, including 8 subjects 39 
who experienced an RV-associated asthma exacerbation (Supplemental Figure 1). From the 21 40 
subjects who experienced asymptomatic infections, we randomly selected 10 subjects for 41 
analysis. Of note, one subject in the asthma exacerbation group was eliminated during analysis 42 
due to insufficient DNA detection during sample processing.  43 
Symptom scoring and asthma diagnosis 44 
 Children scored cold and asthma symptom severity based on a 4-point scoring system 45 
(supplemental Table 2) (3, 4) Moderate asthma exacerbations were defined as at least moderate 46 
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asthma symptoms (score ≥ 2) and either a decrease in PEF of at least 20% or increased use of 47 
albuterol ≥ 2 days, in accordance with NHLBI and ATS definitions.(1, 2)  Current asthma was 48 
diagnosed at study completion based on the above criteria.  49 
 The asthma status of each participant was reported by their parent upon enrollment. Then, 50 
in the main RhinoGen study, we followed asthma symptoms and treatment over one year to 51 
confirm asthma status.  Current asthma was diagnosed at the end of the study period based on the 52 
documented presence of one or more of the following characteristics in the previous year: (1) use 53 
of albuterol for coughing or wheezing episodes (prescribed by physician), (2) use of a daily 54 
controller medication, (3) step-up plan including use of albuterol or short-term use of inhaled 55 
corticosteroids during illness, (4) use of prednisone for asthma exacerbation, and (5) reversibility 56 
of pulmonary function tests after administration of a short-acting beta-agonist. Two separate 57 
investigators, blinded to any antecedent histories concerning viral illnesses or patterns of 58 
aeroallergen sensitization, independently evaluated each subject for the presence or absence of 59 
asthma based on the above criteria. 60 
Sample Analysis 61 
 DNA was extracted from nasal samples using the BiOstic Bacteremia DNA Isolation Kit 62 
(Mo BIO laboratories, Carlsbad, California). Specimens were multiplexed using the 515f/806r 63 
primer set that amplifies the V4–V5 region of the 16S rRNA gene (5, 6).  The primers contain 64 
the appropriate Illumina adapters and the reverse primer contains a 12-base error-correcting 65 
barcode unique to each sample (7). DNA was amplified in triplicate PCR reactions using 66 
TaKaRa ExTaq enzyme mixture (Clontech). The PCR protocol was: 1 cycle of 10 minutes at 95o 67 
C followed by 30 cycles of 95o C for 30 seconds, 55o C for 1 minute, 72 oC for 1 minute and a 68 
final elongation at 72o C for 10 minutes (8). The resulting amplicons were purified with 69 
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UltraClean PCR Clean-Up Kit (MO BIO) and the triplicate reactions were pooled together in 70 
equimolar concentrations (7).  71 
 Sequencing was performed on an Illumina MiSeq (5). The resulting sequence reads were 72 
de-multiplexed using CASAVA software installed on the MiSeq Illumina sequencer producing 73 
6,042,668 sequencing tags. Separate pairs of fastq files were generated for each specimen. The 74 
splicing of forward and reverse fastq files produced an average of 100,710 ± 48,567 tags per 75 
specimen. 76 
Sequence Quality Analysis 77 
 16S rRNA sequence processing and analysis was performed utilizing Mothur (v.1.33.3) 78 
software (9, 10). Raw paired-end fastq sequences of each sample were combined into contigs 79 
using make.contigs from the Mothur package which scans across the alignment and identifies 80 
any positions where the two reads disagree. To improve the quality of our data we excluded the 81 
following: 1) bases with quality score less than 25; 2) sequences with ambiguous bases; 3) 82 
sequences with a read length longer than 275 bp; and 4) duplicated sequences. SILVA-based 83 
bacterial reference alignment (release 119) was used to align the processed reads (11). Maximum 84 
homopolymer length was set to 8 and the gap characters in alignment were removed to improve 85 
the overall alignment quality. Within the Mothur package, we used the UCHIME algorithm to 86 
detect and remove chimera sequences.  87 
Operational Taxonomic Unit (OTU) clustering 88 
 For fragment quality control, we trimmed off both the undesirable 18s fragments, and the 89 
16s fragments from Archaea, chloroplasts, and mitochondria. Using the dist.seqs command, 90 
uncorrected pairwise distances between aligned DNA sequences were calculated and stored in 91 
the column formatted distance matrix. To assign sequences to respective OTUs, clustering was 92 
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performed using the average neighbor method at a 99% identity cut-off level. Finally, 93 
taxonomical classification for each OTU was obtained by using the classify.seqs command 94 
within the Mothur software package (10). 95 
Sequence Analysis 96 
 Rarefaction curves describing the number of OTUs observed as a function of sampling 97 
effort were generated using the sobs calculator in Mothur. Random sub-sampling was performed 98 
to address concerns of different sequencing depths across samples, affecting the rarefaction 99 
curves. To calculate significance between pre and post infection, Pearson's Chi-squared test was 100 
used. Finally, Shannon diversity and evenness and Simpson diversity and evenness indices were 101 
calculated from the sub-sampled OTU abundance data.  102 
 To identify if the presence of OTUs differed significantly between the subject groups, 103 
Fisher’s exact test was performed. The Unifrac and Bray-Curtis distances were calculated 104 
between the community structures of the RV subjects for variation analysis. Principal 105 
coordinates (PCoA), which employs an eigenvector-based approach, was performed with the 106 
Mothur package to represent the multidimensional data of OTU abundance in three dimensions. 107 
Species-axes correlations were obtained by using the corr.axes command with the Mothur 108 
package. 109 
Rhinovirus abundance and microbial association analysis   110 
 For association analysis, individual OTUs were assigned to the lowest available 111 
taxonomy of bacteria, and OTUs not present in at least 4 samples were not included. Next, both 112 
negative (Spearman's ρ <−0.5, P-value <0.05) and positive (Spearman's ρ > 0.5, P-value < 0.05) 113 
Spearman rank-order correlations were calculated between OTU abundance and RV abundance.  114 
  115 
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Supplemental Table I: Demographics between subjects included in this study and the other 116 
RhinoGen participants with asthma. Race/ethnicity: subjects may select more than one category. 117 
 118 
 119 
  120 
 
Children with 
Asymptomatic 
RV Infection 
Children with 
RV-Induced 
Exacerbation 
of Asthma 
Other 
RhinoGen 
Participants 
with Asthma 
P-value 
 
 
  
 
Number of subjects 10 7 150  
 
  
 
Age (y) 8.0 [8.0, 8.7] 6.8 [5.8, 8.1] 8.4 [6.8, 9.6] 0.23 
Gender 2 F, 8 M 1 F, 6 M 52 F, 98 M 0.45 
Race/ethnicity: 
 
  
 
White 100% 100% 87% 0.58 
Black 0% 14% 13% 0.70 
Hispanic or Latino 10% 0% 7% 0.74 
Asian 0% 0% 4% 1.00 
American Indian or Alaskan native 0% 0% 1% 1.00 
Other 0% 0% 2% 1.00 
Pacific Islander or Hawaiian 0% 0% 1% 1.00 
 
  
 
Aeroallergen sensitization 70% 57% 61% 0.85 
Asthma 100% 100% 100% NA 
FeNO 8.3 [7.4, 30.7] 19.2 [8.5, 41.6] 13.8 [8.0, 26.2] 0.87 
Total IgE 318 [32, 497] 146 [96, 262] 125 [37, 388] 0.91 
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Supplemental Table II.  Definition of Cold and Asthma Scores 121 
  Cold Symptoms Asthma Symptoms 
0 Absent None None 
1 Mild Mild stuffy or runny nose but does not 
affect daily activity 
Occasional cough or wheeze but does not 
affect daily activity 
2 Moderate Moderate stuffy or runny nose and reduced 
activity but does not affect sleep 
Frequent cough or wheeze with some 
shortness of breath and reduced activity 
but not affecting sleep 
3 Severe Cannot breathe through the nose and not 
able to sleep well because of symptoms 
Unable to sleep well because of symptoms 
 122 
 123 
 124 
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M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Supplemental Figure 1: Subject Inclusion 126 
 127 
 128 
Supplemental Figure 2: Relative abundance at the Phylum and Genera level between RV-129 
negative and RV-positive samples. Firmicutes q-value=7.62x10-6; Dolosigranulum q-130 
value=1.13x10-8; Moraxella q-value=5.5x10-7; and unclassified OTU #1 q-value=1x10-24.  131 
 132 
 133 
Supplemental Figure 3. Microbial composition of individual samples. First bar in each pair is 134 
uninfected, second bar is RV infected. 135 
 136 
 137 
Supplemental Figure 4: Association networks to examine if a relationship exists between viral 138 
load and bacterial abundance. Each line represents an OTU. Green line = increase in bacterial 139 
abundance as viral load increases.  Red line = decrease in abundance as viral load increases. Size 140 
of circle represents the number of sequences associated with that OTU. Node color represents the 141 
phyla associated with that OTU. Increasing viral load is associated with decreases in 142 
Dolosigranulum, Corynebacterium, Prevotella, Actinomyces and some OTUs of Streptococcus 143 
and Moraxella. However, increased viral shedding is also associated with increases in 144 
Haemophilus and other OTUs of Streptococcus and Moraxella. Readers should note the 145 
following: 1) the position of each node in the network is user-defined, and 2) the structure of the 146 
network does not represent any biological functions.  147 
 148 
  149 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
References 150 
1. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of 151 
Asthma-Summary Report 2007. The Journal of allergy and clinical immunology. 2007;120(5 152 
Suppl):S94-138. Epub 2007/12/06. 153 
2. Proceedings of the ATS workshop on refractory asthma: current understanding, 154 
recommendations, and unanswered questions. American Thoracic Society. American journal of 155 
respiratory and critical care medicine. 2000;162(6):2341-51. Epub 2000/12/09. 156 
3. Kloepfer KM, Olenec JP, Lee WM, Liu G, Vrtis RF, Roberg KA, et al. Increased H1N1 157 
infection rate in children with asthma. American journal of respiratory and critical care medicine. 158 
2012;185(12):1275-9. Epub 2012/03/01. 159 
4. Olenec JP, Kim WK, Lee WM, Vang F, Pappas TE, Salazar LE, et al. Weekly monitoring 160 
of children with asthma for infections and illness during common cold seasons. The Journal of 161 
allergy and clinical immunology. 2010;125(5):1001-6 e1. Epub 2010/04/16. 162 
5. Fierer N, Leff JW, Adams BJ, Nielsen UN, Bates ST, Lauber CL, et al. Cross-biome 163 
metagenomic analyses of soil microbial communities and their functional attributes. Proceedings 164 
of the National Academy of Sciences of the United States of America. 2012;109(52):21390-5. 165 
Epub 2012/12/14. 166 
6. Liu Z, Lozupone C, Hamady M, Bushman FD, Knight R. Short pyrosequencing reads 167 
suffice for accurate microbial community analysis. Nucleic acids research. 2007;35(18):e120. 168 
Epub 2007/09/21. 169 
7. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et 170 
al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. 171 
Proceedings of the National Academy of Sciences of the United States of America. 2011;108 172 
Suppl 1:4516-22. Epub 2010/06/11. 173 
8. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial 174 
community variation in human body habitats across space and time. Science. 175 
2009;326(5960):1694-7. Epub 2009/11/07. 176 
9. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-177 
index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the 178 
MiSeq Illumina sequencing platform. Applied and environmental microbiology. 179 
2013;79(17):5112-20. Epub 2013/06/25. 180 
10. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. 181 
Introducing mothur: open-source, platform-independent, community-supported software for 182 
describing and comparing microbial communities. Applied and environmental microbiology. 183 
2009;75(23):7537-41. Epub 2009/10/06. 184 
11. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, et al. SILVA: a 185 
comprehensive online resource for quality checked and aligned ribosomal RNA sequence data 186 
compatible with ARB. Nucleic acids research. 2007;35(21):7188-96. Epub 2007/10/20. 187 
 188 
 189 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 Supplemental Figure 1 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
Children with 
Asymptomatic 
RV Infection 
Children with 
RV-Induced 
Exacerbation 
of Asthma 
Other 
RhinoGen 
Participants 
with Asthma 
P-value 
 
 
  
 
Number of subjects 10 7 150  
 
  
 
Age (y) 8.0 [8.0, 8.7] 6.8 [5.8, 8.1] 8.4 [6.8, 9.6] 0.23 
Gender 2 F, 8 M 1 F, 6 M 52 F, 98 M 0.45 
Race/ethnicity: 
 
  
 
White 100% 100% 87% 0.58 
Black 0% 14% 13% 0.70 
Hispanic or Latino 10% 0% 7% 0.74 
Asian 0% 0% 4% 1.00 
American Indian or Alaskan native 0% 0% 1% 1.00 
Other 0% 0% 2% 1.00 
Pacific Islander or Hawaiian 0% 0% 1% 1.00 
 
  
 
Aeroallergen sensitization 70% 57% 61% 0.85 
Asthma 100% 100% 100% NA 
FeNO 8.3 [7.4, 30.7] 19.2 [8.5, 41.6] 13.8 [8.0, 26.2] 0.87 
Total IgE 318 [32, 497] 146 [96, 262] 125 [37, 388] 0.91 
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  Cold Symptoms Asthma Symptoms 
0 Absent None None 
1 Mild 
Mild stuffy or runny nose but does not 
affect daily activity 
Occasional cough or wheeze but does not 
affect daily activity 
2 Moderate 
Moderate stuffy or runny nose and reduced 
activity but does not affect sleep 
Frequent cough or wheeze with some 
shortness of breath and reduced activity 
but not affecting sleep 
3 Severe 
Cannot breathe through the nose and not 
able to sleep well because of symptoms 
Unable to sleep well because of symptoms 
 
